{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:20:10Z","timestamp":1792491610507,"version":"4.5.0"},"reference-count":165,"publisher":"Bentham Science Publishers Ltd.","issue":"16","funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico","doi-asserted-by":"publisher","award":["(166092\/2018-5)"],"award-info":[{"award-number":["(166092\/2018-5)"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico","doi-asserted-by":"publisher","award":["(#312292\/2017-1)"],"award-info":[{"award-number":["(#312292\/2017-1)"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2020,12,14]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Female genital tract infections have a high incidence among different age groups and represent\nan important impact on public health. Among them, vaginitis refers to inflammation of the vulva\nand\/or vagina due to the presence of pathogens that cause trichomoniasis, bacterial vaginosis, and vulvovaginal\ncandidiasis. Several discomforts are associated with these infections, as well as pregnancy\ncomplications and the facilitation of HIV transmission and acquisition. The increasing resistance of\nmicroorganisms to drugs used in therapy is remarkable, since women report the recurrence of these\ninfections and associated comorbidities. Different resistant mechanisms already described for the\ndrugs used in the therapy against Trichomonas vaginalis, Candida spp., and Gardnerella vaginalis, as\nwell as aspects related to pathogenesis and treatment, are discussed in this review. This study aims to\ncontribute to drug design, avoiding therapy ineffectiveness due to drug resistance. Effective alternative\ntherapies to treat vaginitis will reduce the recurrence of infections and, consequently, the high costs\ngenerated in the health system, improving women\u2019s well-being.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450121666200804112340","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T08:06:02Z","timestamp":1596614762000},"page":"1672-1686","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Vaginitis: Review on Drug Resistance"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9886-2981","authenticated-orcid":true,"given":"Graziela Vargas","family":"Rigo","sequence":"first","affiliation":[{"name":"Research Group on Trichomonas, Pharmaceutical Sciences Graduate Program, Faculty of Pharmacy, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8334-5105","authenticated-orcid":true,"given":"Tiana","family":"Tasca","sequence":"additional","affiliation":[{"name":"Research Group on Trichomonas, Pharmaceutical Sciences Graduate Program, Faculty of Pharmacy, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12941-020-0347-4","volume":"19","author":"Kalia N.","year":"2020","unstructured":"Kalia N.; Singh J.; Kaur M.; Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review. Ann Clin Microbiol Antimicrob 2020,19(1),5","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1097\/QAD.0b013e3283021a37","volume":"22","author":"Atashili J.","year":"2008","unstructured":"Atashili J.; Poole C.; Ndumbe P.M.; Adimora A.A.; Smith J.S.; Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 2008,22(12),1493-1501","journal-title":"AIDS"},{"key":"ref=3","first-page":"807","volume":"83","author":"Hainer B.L.","year":"2011","unstructured":"Hainer B.L.; Gibson M.V.; Vaginitis. Am Fam Physician 2011,83(7),807-815","journal-title":"Am Fam Physician"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6404a1","volume":"64","author":"Workowski K.A.","year":"2015","unstructured":"Workowski K.A.; Bolan G.A.; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015,64(RR-03),1-137","journal-title":"MMWR Recomm Rep"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3949\/ccjm.84a.15163","volume":"84","author":"Goje O.","year":"2017","unstructured":"Goje O.; Munoz J.L.; Vulvovaginitis: Find the cause to treat it. Cleve Clin J Med 2017,84(3),215-224","journal-title":"Cleve Clin J Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0020-7519(98)00155-6","volume":"29","author":"Kulda J.","year":"1999","unstructured":"Kulda J.; Trichomonads, hydrogenosomes and drug resistance. Int J Parasitol 1999,29(2),199-212","journal-title":"Int J Parasitol"},{"key":"ref=7","first-page":"665","volume":"86","author":"Robinson S.C.","year":"1962","unstructured":"Robinson S.C.; Trichomonal Vaginitis Resistant to Metranidazole. Can Med Assoc J 1962,86(14),665","journal-title":"Can Med Assoc J"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1128\/AAC.00814-06","volume":"50","author":"Schwebke J.R.","year":"2006","unstructured":"Schwebke J.R.; Barrientes F.J.; Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother 2006,50(12),4209-4210","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2471\/BLT.18.228486","volume":"97","author":"Rowley J.","year":"2019","unstructured":"Rowley J.; Vander Hoorn S.; Korenromp E.; Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ 2019,97(8),548-562P","journal-title":"Bull World Health Organ"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/mmi.12455","volume":"91","author":"Leitsch D.","year":"2014","unstructured":"Leitsch D.; Janssen B.D.; Kolarich D.; Johnson P.J.; Duch\u00eane M.; Trichomonas vaginalis flavin reductase 1 and its role in metronidazole resistance. Mol Microbiol 2014,91(1),198-208","journal-title":"Mol Microbiol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1550-7408.1993.tb04915.x","volume":"40","author":"Kulda J.","year":"1993","unstructured":"Kulda J.; Tachezy J.; Cerkasovov\u00e1 A.; In vitro induced anaerobic resistance to metronidazole in Trichomonas vaginalis. J Eukaryot Microbiol 1993,40(3),262-269","journal-title":"J Eukaryot Microbiol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1365-2958.2009.06675.x","volume":"72","author":"Leitsch D.","year":"2009","unstructured":"Leitsch D.; Kolarich D.; Binder M.; Stadlmann J.; Altmann F.; Duch\u00eane M.; Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance. Mol Microbiol 2009,72(2),518-536","journal-title":"Mol Microbiol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/0006-2952(86)90327-8","volume":"35","author":"Yarlett N.","year":"1986","unstructured":"Yarlett N.; Yarlett N.C.; Lloyd D.; Ferredoxin-dependent reduction of nitroimidazole derivatives in drug-resistant and susceptible strains of Trichomonas vaginalis. Biochem Pharmacol [a]1986,35(10),1703-1708","journal-title":"Biochem Pharmacol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0166-6851(92)90156-E","volume":"56","author":"Ellis J.E.","year":"1992","unstructured":"Ellis J.E.; Cole D.; Lloyd D.; Influence of oxygen on the fermentative metabolism of metronidazole-sensitive and resistant strains of Trichomonas vaginalis. Mol Biochem Parasitol 1992,56(1),79-88","journal-title":"Mol Biochem Parasitol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1073\/pnas.89.10.4402","volume":"89","author":"Quon D.V.","year":"1992","unstructured":"Quon D.V.; d\u2019Oliveira C.E.; Johnson P.J.; Reduced transcription of the ferredoxin gene in metronidazole-resistant Trichomonas vaginalis. Proc Natl Acad Sci USA 1992,89(10),4402-4406","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=16","first-page":"402","volume":"8","author":"Heidari S.","year":"2013","unstructured":"Heidari S.; Bandehpour M.; Seyyed-Tabaei S.J.; Ferredoxin gene mutation in iranian trichomonas vaginalis isolates. Iran J Parasitol 2013,8(3),402-407","journal-title":"Iran J Parasitol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0166-6851(02)00025-7","volume":"121","author":"Land K.M.","year":"2002","unstructured":"Land K.M.; Delgadillo M.G.; Johnson P.J.; In vivo expression of ferredoxin in a drug resistant trichomonad increases metronidazole susceptibility. Mol Biochem Parasitol 2002,121(1),153-157","journal-title":"Mol Biochem Parasitol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1046\/j.1365-2958.2003.03791.x","volume":"51","author":"Land K.M.","year":"2004","unstructured":"Land K.M.; Delgadillo-Correa M.G.; Tachezy J.; Targeted gene replacement of a ferredoxin gene in Trichomonas vaginalis does not lead to metronidazole resistance. Mol Microbiol 2004,51(1),115-122","journal-title":"Mol Microbiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1128\/AAC.24.5.667","volume":"24","author":"M\u00fcller M.","year":"1983","unstructured":"M\u00fcller M.; Gorrell T.E.; Metabolism and metronidazole uptake in Trichomonas vaginalis isolates with different metronidazole susceptibilities. Antimicrob Agents Chemother 1983,24(5),667-673","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0166-6851(86)90115-5","volume":"19","author":"Yarlett N.","year":"1986","unstructured":"Yarlett N.; Yarlett N.C.; Lloyd D.; Metronidazole-resistant clinical isolates of Trichomonas vaginalis have lowered oxygen affinities. Mol Biochem Parasitol [b]1986,19(2),111-116","journal-title":"Mol Biochem Parasitol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molbiopara.2010.01.001","volume":"171","author":"Leitsch D.","year":"2010","unstructured":"Leitsch D.; Kolarich D.; Duch\u00eane M.; The flavin inhibitor diphenyleneiodonium renders Trichomonas vaginalis resistant to metronidazole, inhibits thioredoxin reductase and flavin reductase, and shuts off hydrogenosomal enzymatic pathways. Mol Biochem Parasitol 2010,171(1),17-24","journal-title":"Mol Biochem Parasitol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.molbiopara.2012.03.003","volume":"183","author":"Leitsch D.","year":"2012","unstructured":"Leitsch D.; Drini\u0107 M.; Kolarich D.; Duch\u00eane M.; Down-regulation of flavin reductase and alcohol dehydrogenase-1 (ADH1) in metronidazole-resistant isolates of Trichomonas vaginalis. Mol Biochem Parasitol 2012,183(2),177-183","journal-title":"Mol Biochem Parasitol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/jeu.12671","volume":"66","author":"Arg\u00e1ez-Correa W.","year":"2019","unstructured":"Arg\u00e1ez-Correa W.; Alvarez-S\u00e1nchez M.E.; Arana-Arg\u00e1ez V.E.; The Role of Iron Status in the Early Progression of Metronidazole Resistance in Trichomonas vaginalis Under Microaerophilic Conditions. J Eukaryot Microbiol 2019,66(2),309-315","journal-title":"J Eukaryot Microbiol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10534-017-0034-x","volume":"30","author":"Fern\u00e1ndez-Mart\u00edn K.G.","year":"2017","unstructured":"Fern\u00e1ndez-Mart\u00edn K.G.; Alvarez-S\u00e1nchez M.E.; Arana-Arg\u00e1ez V.E.; Alvarez-S\u00e1nchez L.C.; Lara-Riegos J.C.; Torres-Romero J.C.; Genome-wide identification, in silico characterization and expression analysis of ZIP-like genes from Trichomonas vaginalis in response to Zinc and Iron. Biometals 2017,30(5),663-675","journal-title":"Biometals"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00436-006-0215-y","volume":"100","author":"Xiao J.C.","year":"2006","unstructured":"Xiao J.C.; Xie L.F.; Fang S.L.; Symbiosis of Mycoplasma hominis in Trichomonas vaginalis may link metronidazole resistance in vitro. Parasitol Res 2006,100(1),123-130","journal-title":"Parasitol Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00436-018-5761-6","volume":"117","author":"F\u00fcrnkranz U.","year":"2018","unstructured":"F\u00fcrnkranz U.; Henrich B.; Walochnik J.; Mycoplasma hominis impacts gene expression in Trichomonas vaginalis. Parasitol Res 2018,117(3),841-847","journal-title":"Parasitol Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00436-010-1975-y","volume":"107","author":"Butler S.E.","year":"2010","unstructured":"Butler S.E.; Augostini P.; Secor W.E.; Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States. Parasitol Res 2010,107(4),1023-1027","journal-title":"Parasitol Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.meegid.2015.07.005","volume":"34","author":"da Luz Becker D.","year":"2015","unstructured":"da Luz Becker D.; dos Santos O.; Frasson A.P.; de Vargas Rigo G.; Macedo A.J.; Tasca T.; High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil. Infect Genet Evol 2015,34,181-187","journal-title":"Infect Genet Evol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00705-010-0832-8","volume":"156","author":"Goodman R.P.","year":"2011","unstructured":"Goodman R.P.; Ghabrial S.A.; Fichorova R.N.; Nibert M.L.; Trichomonasvirus: a new genus of protozoan viruses in the family Totiviridae. Arch Virol 2011,156(1),171-179","journal-title":"Arch Virol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.resmic.2017.03.005","volume":"168","author":"Fichorova R.","year":"2017","unstructured":"Fichorova R.; Fraga J.; Rappelli P.; Fiori P.L.; Trichomonas vaginalis infection in symbiosis with Trichomonasvirus and Mycoplasma. Res Microbiol 2017,168(9-10),882-891","journal-title":"Res Microbiol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1128\/JCM.38.8.3004-3009.2000","volume":"38","author":"Snipes L.J.","year":"2000","unstructured":"Snipes L.J.; Gamard P.M.; Narcisi E.M.; Beard C.B.; Lehmann T.; Secor W.E.; Molecular epidemiology of metronidazole resistance in a population of Trichomonas vaginalis clinical isolates. J Clin Microbiol 2000,38(8),3004-3009","journal-title":"J Clin Microbiol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4103\/0255-0857.81801","volume":"29","author":"Malla N.","year":"2011","unstructured":"Malla N.; Kaul P.; Sehgal R.; Gupta I.; The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity. Indian J Med Microbiol 2011,29(2),152-157","journal-title":"Indian J Med Microbiol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/BF02877224","volume":"32","author":"Flegr J.","year":"1987","unstructured":"Flegr J.; \u010cerkasov J.; Kulda J.; Tachezy J.; Stokrov\u00e1 J.; The dsRNA of Trichomonas vaginalis is associated with virus-like particles and does not correlate with metronidazole resistance. Folia Microbiol (Praha) 1987,32(4),345-348","journal-title":"Folia Microbiol (Praha)"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1093\/cid\/ciz146","volume":"69","author":"Graves K.J.","year":"2019","unstructured":"Graves K.J.; Ghosh A.P.; Schmidt N.; Trichomonas vaginalis virus (TVV) among women with trichomoniasis and associations with demographics, clinical outcomes, and metronidazole resistance. Clin Infect Dis 2019,69(12),2170-2176","journal-title":"Clin Infect Dis"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1007\/s00436-017-5627-3","volume":"116","author":"Abdel-Magied A.A.","year":"2017","unstructured":"Abdel-Magied A.A.; El-Kholya E.I.; Abou El-Khair S.M.; The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population. Parasitol Res 2017,116(11),3125-3130","journal-title":"Parasitol Res"},{"key":"ref=36","first-page":"9","volume":"5","author":"Kazemi F.","year":"2010","unstructured":"Kazemi F.; Hooshyar H.; Zareikar B.; Study on ITS1 Gene of Iranian Trichomonas vaginalis by Molecular Methods. Iran J Parasitol 2010,5(4),9-14","journal-title":"Iran J Parasitol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1128\/AAC.02370-13","volume":"58","author":"Paulish-Miller T.E.","year":"2014","unstructured":"Paulish-Miller T.E.; Augostini P.; Schuyler J.A.; Trichomonas vaginalis metronidazole resistance is associated with single nucleotide polymorphisms in the nitroreductase genes ntr4Tv and ntr6Tv. Antimicrob Agents Chemother 2014,58(5),2938-2943","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/gbe\/evx110","volume":"9","author":"Bradic M.","year":"2017","unstructured":"Bradic M.; Warring S.D.; Tooley G.E.; Genetic indicators of drug resistance in the highly repetitive genome of trichomonas vaginalis. Genome Biol Evol 2017,9(6),1658-1672","journal-title":"Genome Biol Evol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1086\/647939","volume":"50","author":"L\u00f6fmark S.","year":"2010","unstructured":"L\u00f6fmark S.; Edlund C.; Nord C.E.; Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis 2010,50(Suppl. 1),S16-S23","journal-title":"Clin Infect Dis"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.ajog.2004.05.033","volume":"191","author":"Beigi R.H.","year":"2004","unstructured":"Beigi R.H.; Austin M.N.; Meyn L.A.; Krohn M.A.; Hillier S.L.; Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 2004,191(4),1124-1129","journal-title":"Am J Obstet Gynecol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"e00992","DOI":"10.1128\/genomeA.00992-15","volume":"3","author":"Schuyler J.A.","year":"2015","unstructured":"Schuyler J.A.; Chadwick S.G.; Mordechai E.; Adelson M.E.; Gygax S.E.; Hilbert D.W.; Draft genome sequence of a metronidazole-resistant gardnerella vaginalis isolate. Genome Announc 2015,3(5),e00992-e15","journal-title":"Genome Announc"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"11640","DOI":"10.1038\/srep11640","volume":"5","author":"Castro J.","year":"2015","unstructured":"Castro J.; Alves P.; Sousa C.; Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates. Sci Rep 2015,5,11640","journal-title":"Sci Rep"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3855\/jidc.7161","volume":"10","author":"Knupp de Souza D.M.","year":"2016","unstructured":"Knupp de Souza D.M.; Diniz C.G.; Filho D.S.; Antimicrobial susceptibility and vaginolysin in Gardnerella vaginalis from healthy and bacterial vaginosis diagnosed women. J Infect Dev Ctries 2016,10(9),913-919","journal-title":"J Infect Dev Ctries"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/eva.12555","volume":"11","author":"Cornejo O.E.","year":"2017","unstructured":"Cornejo O.E.; Hickey R.J.; Suzuki H.; Forney L.J.; Focusing the diversity of Gardnerella vaginalis through the lens of ecotypes. Evol Appl 2017,11(3),312-324","journal-title":"Evol Appl"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/01.AOG.0000183594.45524.d2","volume":"106","author":"Swidsinski A.","year":"2005","unstructured":"Swidsinski A.; Mendling W.; Loening-Baucke V.; Adherent biofilms in bacterial vaginosis. Obstet Gynecol 2005,106(5 Pt 1),1013-1023","journal-title":"Obstet Gynecol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"97.e1","DOI":"10.1016\/j.ajog.2007.06.039","volume":"198","author":"Swidsinski A.","year":"2008","unstructured":"Swidsinski A.; Mendling W.; Loening-Baucke V.; An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol 2008,198(1),97.e1-97.e6","journal-title":"Am J Obstet Gynecol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/cid\/civ353","volume":"61","author":"Muzny C.A.","year":"2015","unstructured":"Muzny C.A.; Schwebke J.R.; Biofilms: an underappreciated mechanism of treatment failure and recurrence in vaginal infections. Clin Infect Dis 2015,61(4),601-606","journal-title":"Clin Infect Dis"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41522-017-0012-7","volume":"3","author":"Castro J.","year":"2017","unstructured":"Castro J.; Fran\u00e7a A.; Bradwell K.R.; Serrano M.G.; Jefferson K.K.; Cerca N.; Comparative transcriptomic analysis of Gardnerella vaginalis biofilms vs. planktonic cultures using RNA-seq. NPJ Biofilms Microbiomes 2017,3,3","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/1471-2164-11-375","volume":"11","author":"Harwich M.D.J.","year":"2010","unstructured":"Harwich M.D.J.; Alves J.M.; Buck G.A.; Drawing the line between commensal and pathogenic Gardnerella vaginalis through genome analysis and virulence studies. BMC Genomics 2010,11,375","journal-title":"BMC Genomics"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0022-2836(03)00121-9","volume":"327","author":"Nurizzo D.","year":"2003","unstructured":"Nurizzo D.; Shewry S.C.; Perlin M.H.; The crystal structure of aminoglycoside-3\u2032-phosphotransferase-IIa, an enzyme responsible for antibiotic resistance. J Mol Biol 2003,327(2),491-506","journal-title":"J Mol Biol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1128\/AAC.30.5.810","volume":"30","author":"Roberts M.C.","year":"1986","unstructured":"Roberts M.C.; Hillier S.L.; Hale J.; Holmes K.K.; Kenny G.E.; Tetracycline resistance and tetM in pathogenic urogenital bacteria. Antimicrob Agents Chemother 1986,30(5),810-812","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nrm2646","volume":"10","author":"Rees D.C.","year":"2009","unstructured":"Rees D.C.; Johnson E.; Lewinson O.; ABC transporters: the power to change. Nat Rev Mol Cell Biol 2009,10(3),218-227","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0924-8579(03)00203-6","volume":"22","author":"Lage H.","year":"2003","unstructured":"Lage H.; ABC-transporters: implications on drug resistance from microorganisms to human cancers. Int J Antimicrob Agents 2003,22(3),188-199","journal-title":"Int J Antimicrob Agents"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3389\/fmicb.2018.00975","volume":"9","author":"Mar\u00edn E.","year":"2018","unstructured":"Mar\u00edn E.; Haesaert A.; Padilla L.; Unraveling Gardnerella vaginalis Surface Proteins Using Cell Shaving Proteomics. Front Microbiol 2018,9,975","journal-title":"Front Microbiol"},{"key":"ref=55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012411","volume":"5","author":"Yeoman C.J.","year":"2010","unstructured":"Yeoman C.J.; Yildirim S.; Thomas S.M.; Comparative genomics of Gardnerella vaginalis strains reveals substantial differences in metabolic and virulence potential. PLoS One 2010,5(8)","journal-title":"PLoS One"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1574-6976.2006.00024.x","volume":"30","author":"Macheboeuf P.","year":"2006","unstructured":"Macheboeuf P.; Contreras-Martel C.; Job V.; Dideberg O.; Dessen A.; Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes. FEMS Microbiol Rev 2006,30(5),673-691","journal-title":"FEMS Microbiol Rev"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1128\/JB.00056-12","volume":"194","author":"Ahmed A.","year":"2012","unstructured":"Ahmed A.; Earl J.; Retchless A.; Comparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into genovars. J Bacteriol 2012,194(15),3922-3937","journal-title":"J Bacteriol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diagmicrobio.2015.10.006","volume":"84","author":"Schuyler J.A.","year":"2016","unstructured":"Schuyler J.A.; Mordechai E.; Adelson M.E.; Sobel J.D.; Gygax S.E.; Hilbert D.W.; Identification of intrinsically metronidazole-resistant clades of Gardnerella vaginalis. Diagn Microbiol Infect Dis 2016,84(1),1-3","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mycmed.2014.10.021","volume":"25","author":"Alfouzan W.","year":"2015","unstructured":"Alfouzan W.; Dhar R.; Ashkanani H.; Gupta M.; Rachel C.; Khan Z.U.; Species spectrum and antifungal susceptibility profile of vaginal isolates of Candida in Kuwait. J Mycol Med 2015,25(1),23-28","journal-title":"J Mycol Med"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12905-018-0607-z","volume":"18","author":"Bitew A.","year":"2018","unstructured":"Bitew A.; Abebaw Y.; Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. BMC Womens Health 2018,18(1),94","journal-title":"BMC Womens Health"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1590\/0074-02760160166","volume":"111","author":"Boatto H.F.","year":"2016","unstructured":"Boatto H.F.; Cavalcanti S.D.; Del Negro G.M.; Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil. Mem Inst Oswaldo Cruz 2016,111(6),407-410","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3389\/fmicb.2018.01351","volume":"9","author":"de Oliveira Santos G.C.","year":"2018","unstructured":"de Oliveira Santos G.C.; Vasconcelos C.C.; Lopes A.J.O.; Candida infections and therapeutic strategies: mechanisms of action for traditional and alternative agents. Front Microbiol 2018,9,1351","journal-title":"Front Microbiol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1590\/S1676-24442011000100004","volume":"47","author":"Dalazen D.","year":"2011","unstructured":"Dalazen D.; Zanrosso D.; Wanderley L.; Compara\u00e7\u00e3o do perfil de suscetibilidade entre isolados cl\u00ednicos de Candida spp. orais e vulvovaginais no Sul do Brasil. J Bras Patol Med Lab 2011,47(1),33-38","journal-title":"J Bras Patol Med Lab"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/myc.12204","volume":"57","author":"Zhang J.Y.","year":"2014","unstructured":"Zhang J.Y.; Liu J.H.; Liu F.D.; Vulvovaginal candidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression. Mycoses 2014,57(10),584-591","journal-title":"Mycoses"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bjm.2016.09.006","volume":"48","author":"Brandolt T.M.","year":"2017","unstructured":"Brandolt T.M.; Klafke G.B.; Gon\u00e7alves C.V.; Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates. Braz J Microbiol 2017,48(1),145-150","journal-title":"Braz J Microbiol"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jac\/dkz400","volume":"75","author":"Nishimoto A.T.","year":"2020","unstructured":"Nishimoto A.T.; Sharma C.; Rogers P.D.; Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans. J Antimicrob Chemother 2020,75(2),257-270","journal-title":"J Antimicrob Chemother"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1099\/mic.0.039354-0","volume":"156","author":"Harriott M.M.","year":"2010","unstructured":"Harriott M.M.; Lilly E.A.; Rodriguez T.E.; Fidel P.L.; Noverr M.C.; Candida albicans forms biofilms on the vaginal mucosa. Microbiology 2010,156(Pt 12),3635-3644","journal-title":"Microbiology"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00404-017-4465-y","volume":"296","author":"Nakamura-Vasconcelos S.S.","year":"2017","unstructured":"Nakamura-Vasconcelos S.S.; Fiorini A.; Zanni P.D.; Emergence of Candida glabrata in vulvovaginal candidiasis should be attributed to selective pressure or virulence ability? Arch Gynecol Obstet 2017,296(3),519-526","journal-title":"Arch Gynecol Obstet"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"e01065","DOI":"10.1128\/AAC.01065-17","volume":"61","author":"Sherry L.","year":"2017","unstructured":"Sherry L.; Kean R.; McKloud E.; Biofilms formed by isolates from recurrent vulvovaginal candidiasis patients are heterogeneous and insensitive to fluconazole. Antimicrob Agents Chemother 2017,61(9),e01065-e17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.colsurfb.2018.11.011","volume":"174","author":"Rodr\u00edguez-Cerdeira C.","year":"2019","unstructured":"Rodr\u00edguez-Cerdeira C.; Gregorio M.C.; Molares-Vila A.; Biofilms and vulvovaginal candidiasis. Colloids Surf B Biointerfaces 2019,174,110-125","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4103\/2277-9175.183666","volume":"5","author":"Roudbarmohammadi S.","year":"2016","unstructured":"Roudbarmohammadi S.; Roudbary M.; Bakhshi B.; Katiraee F.; Mohammadi R.; Falahati M.; ALS1 and ALS3 gene expression and biofilm formation in Candida albicans isolated from vulvovaginal candidiasis. Adv Biomed Res 2016,5,105","journal-title":"Adv Biomed Res"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1128\/IAI.73.3.1656-1663.2005","volume":"73","author":"Cheng G.","year":"2005","unstructured":"Cheng G.; Wozniak K.; Wallig M.A.; Fidel P.L.; Trupin S.R.; Hoyer L.L.; Comparison between Candida albicans agglutinin-like sequence gene expression patterns in human clinical specimens and models of vaginal candidiasis. Infect Immun 2005,73(3),1656-1663","journal-title":"Infect Immun"},{"key":"ref=73","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5930489","author":"Monroy-P\u00e9rez E.","year":"2016","unstructured":"Monroy-P\u00e9rez E.; Paniagua-Contreras G.L.; Rodr\u00edguez-Purata P.; High virulence and antifungal resistance in clinical strains of candida albicans. Can J Infect Dis Med Microbiol 2016","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3109\/1040841X.2015.1091805","volume":"42","author":"Gon\u00e7alves B.","year":"2016","unstructured":"Gon\u00e7alves B.; Ferreira C.; Alves C.T.; Henriques M.; Azeredo J.; Silva S.; Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit Rev Microbiol 2016,42(6),905-927","journal-title":"Crit Rev Microbiol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1128\/CMR.00051-08","volume":"22","author":"Cannon R.D.","year":"2009","unstructured":"Cannon R.D.; Lamping E.; Holmes A.R.; Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 2009,22(2),291-321","journal-title":"Clin Microbiol Rev"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fphar.2014.00202","volume":"5","author":"Prasad R.","year":"2014","unstructured":"Prasad R.; Rawal M.K.; Efflux pump proteins in antifungal resistance. Front Pharmacol 2014,5,202","journal-title":"Front Pharmacol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/BF02703742","volume":"26","author":"Kohli A.","year":"2001","unstructured":"Kohli A.; Gupta V.; Krishnamurthy S.; Hasnain S.E.; Prasad R.; Specificity of drug transport mediated by CaMDR1: a major facilitator of Candida albicans. J Biosci 2001,26(3),333-339","journal-title":"J Biosci"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"24","DOI":"10.18869\/acadpub.cmm.2.4.24","volume":"2","author":"Khosravi Rad K.","year":"2016","unstructured":"Khosravi Rad K.; Falahati M.; Roudbary M.; Farahyar S.; Nami S.; Overexpression of MDR-1 and CDR-2 genes in fluconazole resistance of Candida albicans isolated from patients with vulvovaginal candidiasis. Curr Med Mycol 2016,2(4),24-29","journal-title":"Curr Med Mycol"},{"key":"ref=79","first-page":"1217","volume":"15","author":"Feng W.","year":"2018","unstructured":"Feng W.; Yang J.; Yang L.; Research of Mrr1, Cap1 and MDR1 in Candida albicans resistant to azole medications. Exp Ther Med 2018,15(2),1217-1224","journal-title":"Exp Ther Med"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1128\/AAC.01252-16","volume":"60","author":"Bhattacharya S.","year":"2016","unstructured":"Bhattacharya S.; Sobel J.D.; White T.C.; A combination fluorescence assay demonstrates increased efflux pump activity as a resistance mechanism in azole-resistant vaginal candida albicans isolates. Antimicrob Agents Chemother 2016,60(10),5858-5866","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijantimicag.2005.12.005","volume":"27","author":"Cernicka J.","year":"2006","unstructured":"Cernicka J.; Subik J.; Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis. Int J Antimicrob Agents 2006,27(5),403-408","journal-title":"Int J Antimicrob Agents"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/13693780500093838","volume":"43","author":"Ribeiro M.A.","year":"2005","unstructured":"Ribeiro M.A.; Paula C.R.; John R.; Perfect J.R.; Cox G.M.; Phenotypic and genotypic evaluation of fluconazole resistance in vaginal Candida strains isolated from HIV-infected women from Brazil. Med Mycol 2005,43(7),647-650","journal-title":"Med Mycol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1042\/bst0211034","volume":"21","author":"Kelly S.L.","year":"1993","unstructured":"Kelly S.L.; Arnoldi A.; Kelly D.E.; Molecular genetic analysis of azole antifungal mode of action. Biochem Soc Trans 1993,21(4),1034-1038","journal-title":"Biochem Soc Trans"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1128\/AAC.42.12.3065","volume":"42","author":"Franz R.","year":"1998","unstructured":"Franz R.; Kelly S.L.; Lamb D.C.; Kelly D.E.; Ruhnke M.; Morschh\u00e4user J.; Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother 1998,42(12),3065-3072","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0925-4439(02)00087-X","volume":"1587","author":"Morschh\u00e4user J.","year":"2002","unstructured":"Morschh\u00e4user J.; The genetic basis of fluconazole resistance development in Candida albicans. Biochim Biophys Acta 2002,1587(2-3),240-248","journal-title":"Biochim Biophys Acta"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/mmy\/myx099","volume":"56","author":"Wu Y.","year":"2018","unstructured":"Wu Y.; Li C.; Wang Z.; Clonal spread and azole-resistant mechanisms of non-susceptible Candida albicans isolates from vulvovaginal candidiasis patients in three Shanghai maternity hospitals. Med Mycol 2018,56(6),687-694","journal-title":"Med Mycol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1128\/AAC.00118-10","volume":"54","author":"Ge S.H.","year":"2010","unstructured":"Ge S.H.; Wan Z.; Li J.; Xu J.; Li R.Y.; Bai F.Y.; Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China. Antimicrob Agents Chemother 2010,54(8),3126-3131","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1128\/AAC.01413-08","volume":"53","author":"Antonopoulou S.","year":"2009","unstructured":"Antonopoulou S.; Aoun M.; Alexopoulos E.C.; Fenticonazole activity measured by the methods of the european committee on antimicrobial susceptibility testing and clsi against 260 candida vulvovaginitis isolates from two european regions and annotations on the prevalent genotypes. Antimicrob Agents Chemother 2009,53(5),2181-2184","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11046-013-9643-2","volume":"175","author":"G\u00fczel A.B.","year":"2013","unstructured":"G\u00fczel A.B.; D\u00f6\u011fen A.; Ayd\u0131n M.; Genotyping reveals no link between Candida albicans genotype and vaginitis severity in Turkish women. Mycopathologia 2013,175(3-4),287-294","journal-title":"Mycopathologia"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1590\/S0103-40142010000300006","volume":"24","author":"Guido R.V.C.","year":"2010","unstructured":"Guido R.V.C.; Andricopulo A.D.; Oliva G.; Planejamento de f\u00e1rmacos, biotecnologia e qu\u00edmica medicinal: aplica\u00e7\u00f5es em doen\u00e7as infecciosas. Estud Av 2010,24(70),81-98","journal-title":"Estud Av"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1097\/OLQ.0b013e31822037e4","volume":"38","author":"Nyirjesy P.","year":"2011","unstructured":"Nyirjesy P.; Gilbert J.; Mulcahy L.J.; Resistant trichomoniasis: successful treatment with combination therapy. Sex Transm Dis 2011,38(10),962-963","journal-title":"Sex Transm Dis"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejmech.2014.03.076","volume":"79","author":"Anthwal A.","year":"2014","unstructured":"Anthwal A.; Rajesh U.C.; Rawat M.S.; Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis. Eur J Med Chem 2014,79,89-94","journal-title":"Eur J Med Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"e02329","DOI":"10.1128\/AAC.02329-17","volume":"62","author":"Ghosh A.P.","year":"2018","unstructured":"Ghosh A.P.; Aycock C.; Schwebke J.R.; In vitro study of the susceptibility of clinical isolates of trichomonas vaginalis to metronidazole and secnidazole. Antimicrob Agents Chemother 2018,62(4),e02329-e17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ijantimicag.2010.09.006","volume":"37","author":"F\u00fcrnkranz U.","year":"2011","unstructured":"F\u00fcrnkranz U.; Nagl M.; Gottardi W.; Duch\u00eane M.; Asp\u00f6ck H.; Walochnik J.; In vitro activity of N-chlorotaurine (NCT) in combination with NH4Cl against Trichomonas vaginalis. Int J Antimicrob Agents 2011,37(2),171-173","journal-title":"Int J Antimicrob Agents"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/cbdd.12972","volume":"90","author":"Korosh T.","year":"2017","unstructured":"Korosh T.; Bujans E.; Morada M.; Potential of bisbenzimidazole-analogs toward metronidazole-resistant Trichomonas vaginalis isolates. Chem Biol Drug Des 2017,90(4),489-495","journal-title":"Chem Biol Drug Des"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1128\/AAC.38.9.2086","volume":"38","author":"Katiyar S.K.","year":"1994","unstructured":"Katiyar S.K.; Gordon V.R.; McLaughlin G.L.; Edlind T.D.; Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence. Antimicrob Agents Chemother 1994,38(9),2086-2090","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00436-018-5813-y","volume":"117","author":"Chacon M.O.","year":"2018","unstructured":"Chacon M.O.; Fonseca T.H.S.; Oliveira S.B.V.; Chlorinated metronidazole as a promising alternative for treating trichomoniasis. Parasitol Res 2018,117(5),1333-1340","journal-title":"Parasitol Res"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1128\/AAC.00199-11","volume":"55","author":"Jain A.","year":"2011","unstructured":"Jain A.; Lal N.; Kumar L.; Novel trichomonacidal spermicides. Antimicrob Agents Chemother 2011,55(9),4343-4351","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1021\/ml200161t","volume":"3","author":"Kumar L.","year":"2011","unstructured":"Kumar L.; Jain A.; Lal N.; Potentiating metronidazole scaffold against resistant trichomonas: design, synthesis, biology and 3d-qsar analysis. ACS Med Chem Lett [b]2011,3(2),83-87","journal-title":"ACS Med Chem Lett"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s00436-013-3367-6","volume":"112","author":"Ibrahim A.N.","year":"2013","unstructured":"Ibrahim A.N.; Comparison of in vitro activity of metronidazole and garlic-based product (Tomex\u00ae) on Trichomonas vaginalis. Parasitol Res 2013,112(5),2063-2067","journal-title":"Parasitol Res"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ejmech.2016.03.012","volume":"115","author":"Lal N.","year":"2016","unstructured":"Lal N.; Jangir S.; Bala V.; Role of disulfide linkage in action of bis(dialkylaminethiocarbonyl)disulfides as potent double-Edged microbicidal spermicide: Design, synthesis and biology. Eur J Med Chem 2016,115,275-290","journal-title":"Eur J Med Chem"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s00436-011-2798-1","volume":"110","author":"Rocha T.D.","year":"2012","unstructured":"Rocha T.D.; de Brum Vieira P.; Gnoatto S.C.; Tasca T.; Gosmann G.; Anti-Trichomonas vaginalis activity of saponins from Quillaja, Passiflora, and Ilex species. Parasitol Res 2012,110(6),2551-2556","journal-title":"Parasitol Res"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.parint.2012.10.006","volume":"62","author":"Cargnin S.T.","year":"2013","unstructured":"Cargnin S.T.; Vieira Pde B.; Cibulski S.; Anti-Trichomonas vaginalis activity of Hypericum polyanthemum extract obtained by supercritical fluid extraction and isolated compounds. Parasitol Int 2013,62(2),112-117","journal-title":"Parasitol Int"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1007\/s00436-014-3955-0","volume":"113","author":"Innocente A.M.","year":"2014","unstructured":"Innocente A.M.; Vieira Pde B.; Frasson A.P.; Anti-Trichomonas vaginalis activity from triterpenoid derivatives. Parasitol Res 2014,113(8),2933-2940","journal-title":"Parasitol Res"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12639-014-0479-6","volume":"40","author":"Mahmoud M.A.E.A.","year":"2016","unstructured":"Mahmoud M.A.E.A.; Aminou H.A.; Hashem H.A.; Are the fatty acids responsible for the higher effect of oil and alcoholic extract of Nigella sativa over its aqueous extract on Trichomonas vaginalis trophozoites? J Parasit Dis 2016,40(1),22-31","journal-title":"J Parasit Dis"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/13880209.2015.1044617","volume":"54","author":"Dai M.","year":"2016","unstructured":"Dai M.; Peng C.; Peng F.; Xie C.; Wang P.; Sun F.; Anti-Trichomonas vaginalis properties of the oil of Amomum tsao-ko and its major component, geraniol. Pharm Biol 2016,54(3),445-450","journal-title":"Pharm Biol"},{"key":"ref=107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188531","volume":"12","author":"de Brum Vieira P.","year":"2017","unstructured":"de Brum Vieira P.; Silva N.L.F.; Menezes C.B.; Trichomonicidal and parasite membrane damaging activity of bidesmosic saponins from Manilkara rufula. PLoS One 2017,12(11)","journal-title":"PLoS One"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"14906","DOI":"10.1039\/C5DT02378E","volume":"44","author":"Stringer T.","year":"2015","unstructured":"Stringer T.; Taylor D.; Guzgay H.; Polyamine quinoline rhodium complexes: synthesis and pharmacological evaluation as antiparasitic agents against Plasmodium falciparum and Trichomonas vaginalis. Dalton Trans 2015,44(33),14906-14917","journal-title":"Dalton Trans"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.parint.2010.05.003","volume":"59","author":"Vilela R.","year":"2010","unstructured":"Vilela R.; Menna-Barreto R.F.; Benchimol M.; Methyl jasmonate induces cell death and loss of hydrogenosomal membrane potential in Trichomonas vaginalis. Parasitol Int 2010,59(3),387-393","journal-title":"Parasitol Int"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1128\/AAC.00009-13","volume":"57","author":"Mallo N.","year":"2013","unstructured":"Mallo N.; Lamas J.; Leiro J.M.; Hydrogenosome metabolism is the key target for antiparasitic activity of resveratrol against Trichomonas vaginalis. Antimicrob Agents Chemother 2013,57(6),2476-2484","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.phytochem.2011.01.023","volume":"72","author":"Giordani R.B.","year":"2011","unstructured":"Giordani R.B.; Vieira Pde B.; Weizenmann M.; Lycorine induces cell death in the amitochondriate parasite, Trichomonas vaginalis, via an alternative non-apoptotic death pathway. Phytochemistry 2011,72(7),645-650","journal-title":"Phytochemistry"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/cbdd.13002","volume":"90","author":"Menezes C.B.","year":"2017","unstructured":"Menezes C.B.; Rigo G.V.; Bridi H.; The anti-Trichomonas vaginalis phloroglucinol derivative isoaustrobrasilol B modulates extracellular nucleotide hydrolysis. Chem Biol Drug Des 2017,90(5),811-819","journal-title":"Chem Biol Drug Des"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1111\/cbdd.13341","volume":"92","author":"Alam R.","year":"2018","unstructured":"Alam R.; Barbarovich A.T.; Caravan W.; Druggability of the guanosine\/adenosine\/cytidine nucleoside hydrolase from Trichomonas vaginalis. Chem Biol Drug Des 2018,92(4),1736-1742","journal-title":"Chem Biol Drug Des"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.biopha.2008.10.002","volume":"63","author":"Giordani R.B.","year":"2009","unstructured":"Giordani R.B.; De Almeida M.V.; Fernandes E.; Anti-Trichomonas vaginalis activity of synthetic lipophilic diamine and amino alcohol derivatives. Biomed Pharmacother 2009,63(8),613-617","journal-title":"Biomed Pharmacother"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.biopha.2017.09.007","volume":"95","author":"Rigo G.V.","year":"2017","unstructured":"Rigo G.V.; Trein M.R.; da Silva Trentin D.; Diamine derivative anti-Trichomonas vaginalis and anti-Tritrichomonas foetus activities by effect on polyamine metabolism. Biomed Pharmacother 2017,95,847-855","journal-title":"Biomed Pharmacother"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/jac\/dkn223","volume":"62","author":"Tiwari P.","year":"2008","unstructured":"Tiwari P.; Singh D.; Singh M.M.; Anti-Trichomonas activity of Sapindus saponins, a candidate for development as microbicidal contraceptive. J Antimicrob Chemother 2008,62(3),526-534","journal-title":"J Antimicrob Chemother"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1517\/14712598.8.6.719","volume":"8","author":"Kaufmann G.F.","year":"2008","unstructured":"Kaufmann G.F.; Park J.; Janda K.D.; Bacterial quorum sensing: a new target for anti-infective immunotherapy. Expert Opin Biol Ther 2008,8(6),719-724","journal-title":"Expert Opin Biol Ther"},{"key":"ref=118","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1426109","author":"Algburi A.","year":"2018","unstructured":"Algburi A.; Zehm S.; Netrebov V.; Weeks R.; Zubovskiy K.; Chikindas M.L.; Benzoyl peroxide inhibits quorum sensing and biofilm formation by gardnerella vaginalis 14018. Infect Dis Obstet Gynecol 2018","journal-title":"Infect Dis Obstet Gynecol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12602-010-9061-4","volume":"3","author":"Noll K.S.","year":"2011","unstructured":"Noll K.S.; Sinko P.J.; Chikindas M.L.; Elucidation of the molecular mechanism of action of the natural antimicrobial peptide subtilosin against the bacterial vaginosis-associated pathogen Gardnerella vaginalis. Probiotics Antimicrob Proteins 2011,3(1),41-47","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1128\/AAC.05861-11","volume":"56","author":"Noll K.S.","year":"2012","unstructured":"Noll K.S.; Prichard M.N.; Khaykin A.; Sinko P.J.; Chikindas M.L.; The natural antimicrobial peptide subtilosin acts synergistically with glycerol monolaurate, lauric arginate, and \u03b5-poly-L-lysine against bacterial vaginosis-associated pathogens but not human lactobacilli. Antimicrob Agents Chemother 2012,56(4),1756-1761","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3390\/ph6121451","volume":"6","author":"Nazzaro F.","year":"2013","unstructured":"Nazzaro F.; Fratianni F.; De Martino L.; Coppola R.; De Feo V.; Effect of essential oils on pathogenic bacteria. Pharmaceuticals (Basel) 2013,6(12),1451-1474","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2217\/fmb-2016-0184","volume":"12","author":"Machado D.","year":"2017","unstructured":"Machado D.; Gaspar C.; Palmeira-de-Oliveira A.; Thymbra capitata essential oil as potential therapeutic agent against Gardnerella vaginalis biofilm-related infections. Future Microbiol 2017,12,407-416","journal-title":"Future Microbiol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"e00650","DOI":"10.1128\/AAC.00650-17","volume":"61","author":"Algburi A.","year":"2017","unstructured":"Algburi A.; Zhang Y.; Weeks R.; Gemini Cationic Amphiphiles Control Biofilm Formation by Bacterial Vaginosis Pathogens. Antimicrob Agents Chemother 2017,61(12),e00650-e17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1248\/yakushi.129.623","volume":"129","author":"Zhang H.","year":"2009","unstructured":"Zhang H.; Gao A.; Li F.; Zhang G.; Ho H.I.; Liao W.; Mechanism of action of tetrandrine, a natural inhibitor of Candida albicans drug efflux pumps. Yakugaku Zasshi 2009,129(5),623-630","journal-title":"Yakugaku Zasshi"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1055\/s-0029-1185973","volume":"76","author":"Zhang H.","year":"2010","unstructured":"Zhang H.; Wang K.; Zhang G.; Ho H.I.; Gao A.; Synergistic anti-candidal activity of tetrandrine on ketoconazole: an experimental study. Planta Med 2010,76(1),53-61","journal-title":"Planta Med"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/jac\/dkn486","volume":"63","author":"De Seta F.","year":"2009","unstructured":"De Seta F.; Schmidt M.; Vu B.; Essmann M.; Larsen B.; Antifungal mechanisms supporting boric acid therapy of Candida vaginitis. J Antimicrob Chemother 2009,63(2),325-336","journal-title":"J Antimicrob Chemother"},{"key":"ref=127","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftx072","volume":"75","author":"Liao H.","year":"2017","unstructured":"Liao H.; Liu S.; Wang H.; Su H.; Liu Z.; Efficacy of Histatin5 in a murine model of vulvovaginal candidiasis caused by Candida albicans. Pathog Dis 2017,75(6)","journal-title":"Pathog Dis"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"18872","DOI":"10.1074\/jbc.274.27.18872","volume":"274","author":"Koshlukova S.E.","year":"1999","unstructured":"Koshlukova S.E.; Lloyd T.L.; Araujo M.W.; Edgerton M.; Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death. J Biol Chem 1999,274(27),18872-18879","journal-title":"J Biol Chem"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1128\/MMBR.59.2.201-222.1995","volume":"59","author":"Sikkema J.","year":"1995","unstructured":"Sikkema J.; de Bont J.A.; Poolman B.; Mechanisms of membrane toxicity of hydrocarbons. Microbiol Rev 1995,59(2),201-222","journal-title":"Microbiol Rev"},{"key":"ref=130","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/641480","author":"Berretta A.A.","year":"2013","unstructured":"Berretta A.A.; de Castro P.A.; Cavalheiro A.H.; Evaluation of mucoadhesive gels with propolis (epp-af) in preclinical treatment of candidiasis vulvovaginal infection. Evid Based Complement Alternat Med 2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"9405","DOI":"10.3390\/molecules20059405","volume":"20","author":"Shinobu-Mesquita C.S.","year":"2015","unstructured":"Shinobu-Mesquita C.S.; Bonfim-Mendon\u00e7a P.S.; Moreira A.L.; Cellular structural changes in candida albicans caused by the hydroalcoholic extract from sapindus saponaria l. Molecules 2015,20(5),9405-9418","journal-title":"Molecules"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.2147\/IJN.S141949","volume":"12","author":"\u0130zg\u00fc F.","year":"2017","unstructured":"\u0130zg\u00fc F.; Bayram G.; Tosun K.; \u0130zg\u00fc D.; Stratum corneum lipid liposome-encapsulated panomycocin: preparation, characterization, and the determination of antimycotic efficacy against Candida spp. isolated from patients with vulvovaginitis in an in vitro human vaginal epithelium tissue model. Int J Nanomedicine 2017,12,5601-5611","journal-title":"Int J Nanomedicine"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1271\/bbb.69.2200","volume":"69","author":"Izg\u00fc F.","year":"2005","unstructured":"Izg\u00fc F.; Altinbay D.; Sertkaya A.; Enzymic activity of the K5-type yeast killer toxin and its characterization. Biosci Biotechnol Biochem 2005,69(11),2200-2206","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1468-3083.2004.00886.x","volume":"18","author":"Pina-Vaz C.","year":"2004","unstructured":"Pina-Vaz C.; Gon\u00e7alves Rodrigues A.; Pinto E.; Antifungal activity of Thymus oils and their major compounds. J Eur Acad Dermatol Venereol 2004,18(1),73-78","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=135","first-page":"220","volume":"41","author":"Murina F.","year":"2018","unstructured":"Murina F.; Vicariotto F.; Di Francesco S.; Thymol, eugenol and lactobacilli in a medical device for the treatment of bacterial vaginosis and vulvovaginal candidiasis. New Microbiol 2018,41(3),220-224","journal-title":"New Microbiol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/myc.12762","volume":"61","author":"Fernandes L.S.","year":"2018","unstructured":"Fernandes L.S.; Amorim Y.M.; da Silva E.L.; Formulation, stability study and preclinical evaluation of a vaginal cream containing curcumin in a rat model of vulvovaginal candidiasis. Mycoses 2018,61(10),723-730","journal-title":"Mycoses"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/iub.1326","volume":"66","author":"Lee W.","year":"2014","unstructured":"Lee W.; Lee D.G.; An antifungal mechanism of curcumin lies in membrane-targeted action within Candida albicans. IUBMB Life 2014,66(11),780-785","journal-title":"IUBMB Life"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1099\/jmm.0.055467-0","volume":"62","author":"Chen Y.","year":"2013","unstructured":"Chen Y.; Zeng H.; Tian J.; Ban X.; Ma B.; Wang Y.; Antifungal mechanism of essential oil from Anethum graveolens seeds against Candida albicans. J Med Microbiol 2013,62(Pt 8),1175-1183","journal-title":"J Med Microbiol"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1080\/01443615.2018.1432578","volume":"38","author":"Saghafi N.","year":"2018","unstructured":"Saghafi N.; Karjalian M.; Ghazanfarpour M.; The effect of a vaginal suppository formulation of dill (Anethum graveolens) in comparison to clotrimazole vaginal tablet on the treatment of vulvovaginal candidiasis. J Obstet Gynaecol 2018,38(7),985-988","journal-title":"J Obstet Gynaecol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/LGT.0000000000000473","volume":"23","author":"Nyirjesy P.","year":"2019","unstructured":"Nyirjesy P.; Alessio C.; Jandourek A.; Lee J.D.; Sandison T.; Sobel J.D.; CD101 Topical Compared With Oral Fluconazole for Acute Vulvovaginal Candidiasis: A Randomized Controlled Trial. J Low Genit Tract Dis 2019,23(3),226-229","journal-title":"J Low Genit Tract Dis"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/jac\/dkx008","volume":"72","author":"Boikov D.A.","year":"2017","unstructured":"Boikov D.A.; Locke J.B.; James K.D.; Bartizal K.; Sobel J.D.; In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis. J Antimicrob Chemother 2017,72(5),1355-1358","journal-title":"J Antimicrob Chemother"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"S604","DOI":"10.1093\/cid\/civ814","volume":"61","author":"Aguilar-Zapata D.","year":"2015","unstructured":"Aguilar-Zapata D.; Petraitiene R.; Petraitis V.; Echinocandins: The Expanding Antifungal Armamentarium. Clin Infect Dis 2015,61(Suppl. 6),S604-S611","journal-title":"Clin Infect Dis"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.peptides.2015.07.023","volume":"71","author":"Scarsini M.","year":"2015","unstructured":"Scarsini M.; Tomasinsig L.; Arzese A.; D\u2019Este F.; Oro D.; Skerlavaj B.; Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections. Peptides 2015,71,211-221","journal-title":"Peptides"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/jac\/dkl382","volume":"58","author":"Benincasa M.","year":"2006","unstructured":"Benincasa M.; Scocchi M.; Pacor S.; Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J Antimicrob Chemother 2006,58(5),950-959","journal-title":"J Antimicrob Chemother"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/psc.2970","volume":"23","author":"Ng S.M.","year":"2017","unstructured":"Ng S.M.; Yap Y.Y.; Cheong J.W.; Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans. J Pept Sci 2017,23(3),215-221","journal-title":"J Pept Sci"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41429-018-0048-9","volume":"71","author":"Andrade J.T.","year":"2018","unstructured":"Andrade J.T.; Santos F.R.S.; Lima W.G.; Design, synthesis, biological activity and structure-activity relationship studies of chalcone derivatives as potential anti-Candida agents. J Antibiot (Tokyo) 2018,71(8),702-712","journal-title":"J Antibiot (Tokyo)"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"7121","DOI":"10.1128\/AAC.03707-14","volume":"58","author":"Warrilow A.G.","year":"2014","unstructured":"Warrilow A.G.; Hull C.M.; Parker J.E.; The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme. Antimicrob Agents Chemother 2014,58(12),7121-7127","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"624.e1","DOI":"10.1016\/j.ajog.2018.03.001","volume":"218","author":"Brand S.R.","year":"2018","unstructured":"Brand S.R.; Degenhardt T.P.; Person K.; A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 2018,218(6),624.e1-624.e9","journal-title":"Am J Obstet Gynecol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1046\/j.1365-280X.1999.00243.x","volume":"37","author":"Niwano Y.","year":"1999","unstructured":"Niwano Y.; Koga H.; Kodama H.; Kanai K.; Miyazaki T.; Yamaguchi H.; Inhibition of sterol 14 alpha-demethylation of Candida albicans with NND-502, a novel optically active imidazole antimycotic agent. Med Mycol 1999,37(5),351-355","journal-title":"Med Mycol"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.mycmed.2017.11.004","volume":"28","author":"Taghipour S.","year":"2018","unstructured":"Taghipour S.; Kiasat N.; Shafiei S.; Halvaeezadeh M.; Rezaei-Matehkolaei A.; Zarei Mahmoudabadi A.; Luliconazole, a new antifungal against Candida species isolated from different sources. J Mycol Med 2018,28(2),374-378","journal-title":"J Mycol Med"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1099\/jmm.0.000082","volume":"64","author":"Kasper L.","year":"2015","unstructured":"Kasper L.; Miram\u00f3n P.; Jablonowski N.; Antifungal activity of clotrimazole against Candida albicans depends on carbon sources, growth phase and morphology. J Med Microbiol 2015,64(7),714-723","journal-title":"J Med Microbiol"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1159\/000453134","volume":"40","author":"Gao M.","year":"2016","unstructured":"Gao M.; Wang H.; Zhu L.; Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis. Cell Physiol Biochem 2016,40(3-4),727-742","journal-title":"Cell Physiol Biochem"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jep.2018.05.018","volume":"223","author":"Yang L.","year":"2018","unstructured":"Yang L.; Wu H.; Qiu W.; Pulsatilla decoction inhibits Candida albicans proliferation and adhesion in a mouse model of vulvovaginal candidiasis via the Dectin-1 signaling pathway. J Ethnopharmacol [a]2018,223,51-62","journal-title":"J Ethnopharmacol"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1111\/j.1365-2672.2008.03912.x","volume":"105","author":"Low C.F.","year":"2008","unstructured":"Low C.F.; Chong P.P.; Yong P.V.; Lim C.S.; Ahmad Z.; Othman F.; Inhibition of hyphae formation and SIR2 expression in Candida albicans treated with fresh Allium sativum (garlic) extract. J Appl Microbiol 2008,105(6),2169-2177","journal-title":"J Appl Microbiol"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/1471-0528.12518","volume":"121","author":"Watson C.J.","year":"2014","unstructured":"Watson C.J.; Grando D.; Fairley C.K.; The effects of oral garlic on vaginal candida colony counts: a randomised placebo controlled double-blind trial. BJOG 2014,121(4),498-506","journal-title":"BJOG"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3109\/13693786.2013.795294","volume":"51","author":"de Freitas Ara\u00fajo M.G.","year":"2013","unstructured":"de Freitas Ara\u00fajo M.G.; Pac\u00edfico M.; Vilegas W.; Evaluation of Syngonanthus nitens (Bong.) Ruhl. extract as antifungal and in treatment of vulvovaginal candidiasis. Med Mycol 2013,51(7),673-682","journal-title":"Med Mycol"},{"key":"ref=157","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17081368","volume":"17","author":"Dos Santos Ramos M.A.","year":"2016","unstructured":"Dos Santos Ramos M.A.; de Toledo L.G.; Calixto G.M.; Syngonanthus nitens Bong. (Rhul.)-Loaded Nanostructured System for Vulvovaginal Candidiasis Treatment. Int J Mol Sci 2016,17(8)","journal-title":"Int J Mol Sci"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1128\/AAC.01451-12","volume":"57","author":"Kato I.T.","year":"2013","unstructured":"Kato I.T.; Prates R.A.; Sabino C.P.; Antimicrobial photodynamic inactivation inhibits Candida albicans virulence factors and reduces in vivo pathogenicity. Antimicrob Agents Chemother 2013,57(1),445-451","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=159","first-page":"275","volume":"11","author":"Machado-de-Sena RM","year":"2014","unstructured":"Machado-de-Sena RM; Corr\u00eaa L; Kato IT; Photodynamic therapy has antifungal effect and reduces inflammatory signals in Candida albicans-induced murine vaginitis Photodiagnosis Photodyn Ther 2014,11(3),275-82"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13568-016-0281-1","volume":"6","author":"Li T.","year":"2016","unstructured":"Li T.; Niu X.; Zhang X.; Wang S.; Liu Z.; Baofukang suppository promotes the repair of vaginal epithelial cells in response to Candida albicans. AMB Express 2016,6(1),109","journal-title":"AMB Express"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/1348-0421.12538","volume":"61","author":"Vrablikova A.","year":"2017","unstructured":"Vrablikova A.; Czernekova L.; Cahlikova R.; Lasioglossins LLIII affect the morphogenesis of Candida albicans and reduces the duration of experimental vaginal candidiasis in mice. Microbiol Immunol 2017,61(11),474-481","journal-title":"Microbiol Immunol"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.fgb.2013.07.001","volume":"60","author":"de Castro P.A.","year":"2013","unstructured":"de Castro P.A.; Bom V.L.; Brown N.A.; Identification of the cell targets important for propolis-induced cell death in Candida albicans. Fungal Genet Biol 2013,60,74-86","journal-title":"Fungal Genet Biol"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.micpath.2013.07.003","volume":"64","author":"Tian J.","year":"2013","unstructured":"Tian J.; Weng L.X.; Zhang Y.Q.; Wang L.H.; BDSF inhibits Candida albicans adherence to urinary catheters. Microb Pathog 2013,64,33-38","journal-title":"Microb Pathog"},{"key":"ref=164","first-page":"816","volume":"31","author":"Yang D.L.","year":"2018","unstructured":"Yang D.L.; Zhang Y.Q.; Hu Y.L.; Weng L.X.; Zeng G.S.; Wang L.H.; Protective Effects of cis-2-Dodecenoic Acid in an Experimental Mouse Model of Vaginal Candidiasis. Biomed Environ Sci 2018,31(11),816-828","journal-title":"Biomed Environ Sci"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1093\/infdis\/jiw159","volume":"214","author":"Bradshaw C.S.","year":"2016","unstructured":"Bradshaw C.S.; Sobel J.D.; Current treatment of bacterial vaginosis-limitations and need for innovation. J Infect Dis 2016,214(Suppl. 1),S14-S20","journal-title":"J Infect Dis"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/184526","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184526\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/184526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T14:21:09Z","timestamp":1629901269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184526\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":165,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2020,12,14]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450121666200804112340","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,14]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-04-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}